Works matching IS 00070920 AND DT 2012 AND VI 106 AND IP 1

Results: 38

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer.

Published in:

2012

By:

Ferdinande L;
Decaestecker C;
Verset L;
Mathieu A;
Moles Lopez X;
Negulescu AM;
Van Maerken T;
Salmon I;
Cuvelier CA;
Demetter P;
Ferdinande, L;
Decaestecker, C;
Verset, L;
Mathieu, A;
Moles Lopez, X;
Negulescu, A-M;
Van Maerken, T;
Salmon, I;
Cuvelier, C A;
Demetter, P

Publication type:

journal article

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.

Published in:

2012

By:

Scaggiante B;
Dapas B;
Bonin S;
Grassi M;
Zennaro C;
Farra R;
Cristiano L;
Siracusano S;
Zanconati F;
Giansante C;
Grassi G;
Scaggiante, B;
Dapas, B;
Bonin, S;
Grassi, M;
Zennaro, C;
Farra, R;
Cristiano, L;
Siracusano, S;
Zanconati, F

Publication type:

journal article

Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 99, doi. 10.1038/bjc.2011.530

By:

Ketola, K;
Hilvo, M;
Hyötyläinen, T;
Vuoristo, A;
Ruskeepää, A-L;
Orešič, M;
Kallioniemi, O;
Iljin, K

Publication type:

Article

Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 199, doi. 10.1038/bjc.2011.501

By:

Allin, K H;
Bojesen, S E;
Johansen, J S;
Nordestgaard, B G

Publication type:

Article

Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.

Published in:

2012

By:

Polesel J;
Gheit T;
Talamini R;
Shahzad N;
Lenardon O;
Sylla B;
La Vecchia C;
Serraino D;
Tommasino M;
Franceschi S;
Polesel, J;
Gheit, T;
Talamini, R;
Shahzad, N;
Lenardon, O;
Sylla, B;
La Vecchia, C;
Serraino, D;
Tommasino, M;
Franceschi, S

Publication type:

journal article

Exploring the use and impact of adjuvant trastuzumab for HER2-positive breast cancer patients in a large UK cancer network. Do the results of international clinical trials translate into a similar benefit for patients in South East Wales?

Published in:

2012

By:

Webster RM;
Abraham J;
Palaniappan N;
Caley A;
Jasani B;
Barrett-Lee P;
Webster, R M;
Abraham, J;
Palaniappan, N;
Caley, A;
Jasani, B;
Barrett-Lee, P

Publication type:

journal article

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 166, doi. 10.1038/bjc.2011.500

By:

Scaggiante, B;
Dapas, B;
Bonin, S;
Grassi, M;
Zennaro, C;
Farra, R;
Cristiano, L;
Siracusano, S;
Zanconati, F;
Giansante, C;
Grassi, G

Publication type:

Article

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 25, doi. 10.1038/bjc.2011.531

By:

Bartsch, R;
Berghoff, A;
Pluschnig, U;
Bago-Horvath, Z;
Dubsky, P;
Rottenfusser, A;
DeVries, C;
Rudas, M;
Fitzal, F;
Dieckmann, K;
Mader, R M;
Gnant, M;
Zielinski, C C;
Steger, G G

Publication type:

Article

Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 85, doi. 10.1038/bjc.2011.514

By:

Algazi, A P;
Weber, J S;
Andrews, S C;
Urbas, P;
Munster, P N;
DeConti, R C;
Hwang, J;
Sondak, V K;
Messina, J L;
McCalmont, T;
Daud, A I

Publication type:

Article

Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 14, doi. 10.1038/bjc.2011.544

By:

Davies, J E;
Neidle, S;
Taylor, D G

Publication type:

Article

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 39, doi. 10.1038/bjc.2011.541

By:

Chéreau, E;
Feron, J-G;
Ballester, M;
Coutant, C;
Bezu, C;
Rouzier, R;
Touboul, E;
Daraï, E

Publication type:

Article

Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 45, doi. 10.1038/bjc.2011.496

By:

Castañon, A;
Tristram, A;
Mesher, D;
Powell, N;
Beer, H;
Ashman, S;
Rieck, G;
Fielder, H;
Fiander, A;
Sasieni, P

Publication type:

Article

Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 70, doi. 10.1038/bjc.2011.499

By:

McMeekin, S;
Patel, R;
Verschraegen, C;
Celano, P;
Burke, J;
Plaxe, S;
Ghatage, P;
Giurescu, M;
Stredder, C;
Wang, Y;
Schmelter, T

Publication type:

Article

Enhancing the immunogenicity of tumour lysate-loaded dendritic cell vaccines by conjugation to virus-like particles.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 92, doi. 10.1038/bjc.2011.538

By:

Win, S J;
McMillan, D G G;
Errington-Mais, F;
Ward, V K;
Young, S L;
Baird, M A;
Melcher, A A

Publication type:

Article

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 141, doi. 10.1038/bjc.2011.513

By:

Ferdinande, L;
Decaestecker, C;
Verset, L;
Mathieu, A;
Moles Lopez, X;
Negulescu, A-M;
Van Maerken, T;
Salmon, I;
Cuvelier, C A;
Demetter, P

Publication type:

Article

Potential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 126, doi. 10.1038/bjc.2011.505

By:

Tsuji, S;
Midorikawa, Y;
Takahashi, T;
Yagi, K;
Takayama, T;
Yoshida, K;
Sugiyama, Y;
Aburatani, H

Publication type:

Article

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 18, doi. 10.1038/bjc.2011.498

By:

Gilbert, D C;
Chalmers, A J;
El-Khamisy, S F

Publication type:

Article

Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 53, doi. 10.1038/bjc.2011.469

By:

Hur, H;
Kim, N K;
Kim, H G;
Min, B S;
Lee, K Y;
Shin, S J;
Cheon, J H;
Choi, S H

Publication type:

Article

Risk of prostate cancer in a population-based cohort of men with coeliac disease.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 217, doi. 10.1038/bjc.2011.536

By:

Ludvigsson, J F;
Fall, K;
Montgomery, S

Publication type:

Article

Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 189, doi. 10.1038/bjc.2011.510

By:

Goebel, G;
Berger, R;
Strasak, A M;
Egle, D;
Müller-Holzner, E;
Schmidt, S;
Rainer, J;
Presul, E;
Parson, W;
Lang, S;
Jones, A;
Widschwendter, M;
Fiegl, H

Publication type:

Article

Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 6, doi. 10.1038/bjc.2011.516

By:

Tsang, R Y;
Finn, R S

Publication type:

Article

Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 206, doi. 10.1038/bjc.2011.502

By:

Chang, C M;
Yu, K J;
Hsu, W L;
Major, J M;
Chen, J Y;
Lou, P J;
Liu, M Y;
Diehl, S R;
Goldstein, A M;
Chen, C J;
Hildesheim, A

Publication type:

Article

Aspirin as adjuvant therapy in childhood cancer?

Published in:

2012

By:

Morgan, G

Publication type:

Letter

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 133, doi. 10.1038/bjc.2011.504

By:

Zeestraten, E C M;
Maak, M;
Shibayama, M;
Schuster, T;
Nitsche, U;
Matsushima, T;
Nakayama, S;
Gohda, K;
Friess, H;
van de Velde, C J H;
Ishihara, H;
Rosenberg, R;
Kuppen, P J K;
Janssen, K-P

Publication type:

Article

A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 227, doi. 10.1038/bjc.2011.512

By:

Kabat, G C;
Kim, M Y;
Strickler, H D;
Shikany, J M;
Lane, D;
Luo, J;
Ning, Y;
Gunter, M J;
Rohan, T E

Publication type:

Article

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 77, doi. 10.1038/bjc.2011.527

By:

Pili, R;
Salumbides, B;
Zhao, M;
Altiok, S;
Qian, D;
Zwiebel, J;
Carducci, M A;
Rudek, M A

Publication type:

Article

Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 210, doi. 10.1038/bjc.2011.525

By:

Green, J;
Roddam, A;
Pirie, K;
Kirichek, O;
Reeves, G;
Beral, V

Publication type:

Article

Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 116, doi. 10.1038/bjc.2011.532

By:

Chang, J;
Varghese, D S;
Gillam, M C;
Peyton, M;
Modi, B;
Schiltz, R L;
Girard, L;
Martinez, E D

Publication type:

Article

A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 148, doi. 10.1038/bjc.2011.465

By:

Bryant, J L;
Britson, J;
Balko, J M;
Willian, M;
Timmons, R;
Frolov, A;
Black, E P

Publication type:

Article

Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 182, doi. 10.1038/bjc.2011.509

By:

Kurashige, J;
Watanabe, M;
Iwatsuki, M;
Kinoshita, K;
Saito, S;
Hiyoshi, Y;
Kamohara, H;
Baba, Y;
Mimori, K;
Baba, H

Publication type:

Article

Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study.

Published in:

2012

By:

Bradley, M C;
Murray, L J;
Cantwell, M M;
Hughes, C M

Publication type:

Case Study

Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 222, doi. 10.1038/bjc.2011.519

By:

Polesel, J;
Gheit, T;
Talamini, R;
Shahzad, N;
Lenardon, O;
Sylla, B;
La Vecchia, C;
Serraino, D;
Tommasino, M;
Franceschi, S

Publication type:

Article

Investigating prostate cancer tumour-stroma interactions: clinical and biological insights from an evolutionary game.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 174, doi. 10.1038/bjc.2011.517

By:

Basanta, D;
Scott, J G;
Fishman, M N;
Ayala, G;
Hayward, S W;
Anderson, A R A

Publication type:

Article

Exploring the use and impact of adjuvant Trastuzumab for HER2-positive breast cancer patients in a large UK cancer networkDo the results of international clinical trials translate into a similar benefit for patients in South East Wales?

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 32, doi. 10.1038/bjc.2011.506

By:

Webster, R M;
Abraham, J;
Palaniappan, N;
Caley, A;
Jasani, B;
Barrett-Lee, P

Publication type:

Article

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 61, doi. 10.1038/bjc.2011.526

By:

Goldstein, D;
Spry, N;
Cummins, M M;
Brown, C;
van Hazel, G A;
Carroll, S;
Selva-Nayagam, S;
Borg, M;
Ackland, S P;
Wratten, C;
Shapiro, J;
Porter, I W T;
Hruby, G;
Horvath, L;
Bydder, S;
Underhill, C;
Harvey, J;
Gebski, V J

Publication type:

Article

Preclinical evaluation of dual PI3K-mTOR inhibitors and histone deacetylase inhibitors in head and neck squamous cell carcinoma.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 107, doi. 10.1038/bjc.2011.495

By:

Erlich, R B;
Kherrouche, Z;
Rickwood, D;
Endo-Munoz, L;
Cameron, S;
Dahler, A;
Hazar-Rethinam, M;
de Long, L M;
Wooley, K;
Guminski, A;
Saunders, N A

Publication type:

Article

Identification of markers of prostate cancer progression using candidate gene expression.

Published in:

British Journal of Cancer, 2012, v. 106, n. 1, p. 157, doi. 10.1038/bjc.2011.490

By:

Larkin, S E T;
Holmes, S;
Cree, I A;
Walker, T;
Basketter, V;
Bickers, B;
Harris, S;
Garbis, S D;
Townsend, P A;
Aukim-Hastie, C

Publication type:

Article

Personalised cancer follow-up: risk stratification, needs assessment or both?

Published in:

2012

By:

Watson, E K;
Rose, P W;
Neal, R D;
Hulbert-Williams, N;
Donnelly, P;
Hubbard, G;
Elliott, J;
Campbell, C;
Weller, D;
Wilkinson, C

Publication type:

Editorial